Intangible Assets

Goodwill



(In millions)	CooperVision			CooperSurgical			Total
Balance at October 31, 2017	$	1,735.7		$	619.1		$	2,354.8
Net additions during the year ended October 31, 2018	36.8			34.4			71.2
Translation	(29.6		)	(4.3		)	(33.9		)
Balance at October 31, 2018	1,742.9			649.2			2,392.1
Net additions during the three months ended January 31, 2019	13.9			21.9			35.8
Translation	19.9			1.5			21.4
Balance at January 31, 2019	$	1,776.7		$	672.6		$	2,449.3

The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill and evaluates its goodwill balances and tests them for impairment in accordance with related accounting standards. The Company performed its annual impairment assessment in its third quarters of fiscal 2018 and fiscal 2017 respectively, and its analysis indicated that the Company had no impairment of goodwill.

Other Intangible Assets



	January 31, 2019				October 31, 2018
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted Average Amortization Period (In years)

Trademarks	$	149.3	$	19.4	$	139.2	$	16.9	14
Composite intangible asset	1,061.9		88.5		1,061.9		70.8		15
Technology	405.8		198.5		395.0		190.7		11
Customer relationships	359.0		175.3		350.0		168.6		13
License and distribution rights and other	76.0		56.2		74.9		52.7		9
	2,052.0		$	537.9	2,021.0		$	499.7	14
Less: accumulated amortization and translation	537.9				499.7
Other intangible assets, net	$	1,514.1			$	1,521.3

Balances include foreign currency translation adjustments.

As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:



Fiscal years:	(In millions)
Remainder of 2019	$	109.1
2020	136.1
2021	134.8
2022	132.9
2023	130.7
Thereafter	861.6
Total remaining amortization for intangible assets	$	1,505.2